20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is AZACITIDINE, with a corresponding US DMF Number 23564.
Remarkably, this DMF maintains an Active status since its submission on February 23, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 20, 2020, and payment made on November 17, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II